felin
infecti
periton
fip
fatal
diseas
domest
wild
felida
caus
felin
coronaviru
fcov
fcov
classifi
type
ii
sinc
type
fcov
infect
domin
field
necessari
develop
antivir
agent
vaccin
type
fcov
infect
howev
studi
conduct
type
fcov
compar
effect
cholesterol
type
ii
fcov
infect
cell
treat
methylbcyclodextrin
mbcd
inocul
type
fcov
infect
rate
decreas
significantli
addit
exogen
cholesterol
mbcdtreat
cell
result
recoveri
infect
type
fcov
furthermor
exogen
cholesterol
increas
infect
type
fcov
contrast
addit
mbcd
exogen
cholesterol
littl
effect
effici
type
ii
fcov
infect
result
strongli
suggest
depend
infect
type
ii
fcov
cholesterol
differ
coronavirus
singlepositivestrand
rna
virus
genom
size
approxim
kbp
belong
famili
coronavirida
subfamili
coronavirina
subfamili
coronavirina
classifi
four
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
cat
felin
coronaviru
fcov
genu
alphacoronaviru
identifi
fcov
virion
mainli
compos
nucleocapsid
n
envelop
e
membran
peplom
spike
protein
two
genotypesserotyp
fcov
fcov
classifi
type
ii
base
amino
acid
sequenc
protein
type
ii
fcov
previous
suggest
produc
recombin
type
fcov
type
ii
canin
coronaviru
ccov
separ
genotypesserotyp
fcov
classifi
two
biotyp
weakli
pathogen
felin
enter
coronaviru
fecv
lowvirul
fcov
strongli
pathogen
felin
infecti
periton
viru
fipv
virul
fcov
etiolog
pathogenesi
fecvfipv
yet
elucid
detail
two
theori
current
exist
intern
mutat
theori
circul
virul
avirul
theori
fipv
caus
fatal
diseas
call
fip
wild
domest
cat
although
antivir
agent
vaccin
fipv
infect
investig
method
yet
establish
practic
use
sinc
type
fcov
infect
domin
field
antivir
agent
vaccin
need
develop
type
fcov
infect
howev
type
ii
fcov
mainli
use
studi
fip
propag
type
fcov
felin
cell
line
monocytesmacrophag
weaker
type
ii
fcov
although
recombin
type
fcov
recent
prepar
revers
genet
studi
type
fcov
progress
differ
identifi
follow
event
type
ii
fcov
replic
abil
cell
line
monocytesmacrophag
amino
acid
sequenc
immunogen
protein
viru
receptor
use
enter
cell
tsutomu
hohdatsu
hohdatsu
vmaskitasatouacjp
howev
differ
event
remain
unclear
viru
receptor
type
fcov
yet
identifi
cholesterol
essenti
compon
anim
cell
shown
play
role
viral
infect
cell
exampl
host
cell
cholesterol
level
shown
influenc
replic
human
hepat
c
viru
hcv
human
immunodefici
viru
dengu
viru
vesicular
stomat
viru
vsv
furthermor
cholesterol
contain
envelop
influenza
viru
shown
affect
infect
cell
cholesterol
contain
host
cell
previous
report
involv
host
cell
infect
mous
hepat
viru
mhv
sever
acut
respiratori
syndrom
coronaviru
sarscov
like
fcov
belong
famili
coronavirida
transmiss
gastroenter
viru
tgev
type
ii
ccov
infect
involv
cellular
viral
cholesterol
protein
type
ii
fcov
homolog
tgev
type
ii
ccov
infect
cell
type
ii
fcov
previous
shown
slightli
influenc
cholesterol
hand
relationship
type
fcov
cholesterol
remain
investig
present
studi
determin
whether
cellular
viral
cholesterol
level
influenc
infect
fcov
type
ii
cell
cultur
feli
catu
whole
fetu
fcwf
cell
kindli
suppli
dr
c
horzinek
state
univers
utrecht
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
u
penicillin
lg
streptomycin
per
ml
type
fcov
strain
fcovi
isol
laboratori
type
fcov
black
strain
fcovi
black
type
fcov
strain
fcovi
kindli
suppli
dr
j
k
yamamoto
univers
florida
type
ii
fcov
strain
fcovii
kindli
provid
dr
c
horzinek
vsv
new
jersey
strain
obtain
laboratori
veterinari
microbiolog
kitasato
univers
virus
grown
cell
methylbcyclodextrin
mbcd
watersolubl
cholesterol
obtain
sigma
aldrich
usa
compound
dilut
desir
concentr
mainten
medium
cellular
cholesterol
content
cell
evalu
use
cholesterol
cellbas
detect
assay
kit
cayman
chemic
usa
accord
manufactur
instruct
briefli
cell
grown
labtek
chamber
slide
thermo
fisher
scientif
usa
confluent
cell
monolay
cultur
medium
contain
mm
mbcd
min
wash
pb
cell
cultur
medium
contain
mg
watersolubl
cholesterol
per
ml
min
fix
stain
filipiniiibind
cell
analyz
use
leica
fluoresc
microscop
germani
cell
viabil
measur
use
assay
describ
previous
briefli
cell
seed
plate
mbcd
watersolubl
cholesterol
ad
triplic
well
hour
cultur
supernat
remov
solut
cell
prolifer
assay
kit
kishida
chemic
co
ltd
japan
ad
cell
return
incub
hour
absorb
formazan
produc
measur
nm
use
spectrophotometr
plate
reader
describ
manufactur
cytotox
calcul
use
follow
formula
cytotox
od
untreat
cell
compoundtr
cell
od
compounduntr
cell
method
deplet
cholesterol
cell
modifi
describ
ren
et
al
briefli
confluent
cell
monolay
cultur
medium
contain
mbcd
rang
mm
multipl
min
wash
phosphatebuff
salin
pb
viru
multipl
infect
moi
adsorb
cell
hour
wash
cell
cultur
mainten
medium
carboxymethyl
cellulos
cmcmem
cell
monolay
incub
hour
fix
stain
crystal
violet
solut
contain
buffer
formalin
plaqu
count
percentag
plaqu
decreas
increas
determin
use
follow
formula
percentag
plaqu
number
plaqu
number
compoundtr
cell
plaqu
number
untreat
cell
method
replenish
cholesteroldeplet
cell
modifi
describ
ren
et
al
briefli
confluent
cell
monolay
cultur
medium
contain
mm
mbcd
multipl
min
wash
pb
cell
cultur
medium
contain
watersolubl
cholesterol
rang
mgml
min
cell
wash
viru
moi
adsorb
onto
cell
hour
wash
cell
cultur
cmcmem
medium
without
carboxymethyl
cellulos
mem
case
cultur
cmcmem
cell
monolay
incub
hour
fix
stain
crystal
violet
solut
contain
buffer
formalin
result
plaqu
count
percentag
plaqu
determin
method
describ
mem
use
cultur
supernat
collect
hour
postinfect
viru
titer
determin
tcid
assay
immunofluoresc
assay
cell
grown
labtek
chamber
slide
thermo
fisher
scientif
usa
confluent
cell
monolay
cultur
medium
contain
mm
mbcd
min
wash
pb
cell
cultur
medium
contain
mg
watersolubl
cholesterol
per
ml
min
cell
wash
viru
moi
adsorb
cell
hour
wash
cell
cultur
mem
cell
monolay
incub
hour
n
protein
level
determin
immunofluoresc
assay
ifa
describ
previous
method
deplet
replenish
cholesterol
viru
modifi
describ
pratelli
colao
briefli
viru
moi
incub
medium
contain
mm
mbcd
hour
order
specif
determin
whether
cholesterol
deplet
mbcd
affect
number
plaqu
caus
fcov
mbcdtreat
fcov
adsorb
onto
cell
hour
mbcdtreat
viral
suspens
dilut
medium
infect
avoid
carryov
effect
mbcd
cell
wash
cell
cultur
cmcmem
mem
order
analyz
infect
effici
viral
cholesterol
replenish
viru
moi
incub
medium
contain
mm
mbcd
min
mbcdtreat
viral
suspens
incub
medium
contain
watersolubl
cholesterol
rang
mgml
hour
cholesteroland
mbcdtreat
fcov
adsorb
onto
cell
hour
order
specif
determin
whether
cholesterol
replenish
affect
number
plaqu
caus
fcov
attempt
avoid
carryov
effect
cholesterol
mbcd
cell
cholesteroland
mbcdtreat
viral
suspens
dilut
medium
infect
cell
wash
viru
adsorb
onto
cell
hour
wash
cell
cultur
cmcmem
hour
cell
fix
stain
crystal
violet
solut
contain
buffer
formalin
result
plaqu
count
number
plaqu
express
percentag
control
measur
method
describ
data
two
group
analyz
student
ttest
welch
ttest
bartlett
test
multipl
group
analyz
oneway
anova
follow
tukey
test
cytotox
effect
mbcd
exogen
cholesterol
cell
shown
tabl
exogen
cholesterol
slightli
exhibit
cytotox
mgml
investig
chang
cellular
cholesterol
content
cell
treat
mbcd
watersolubl
cholesterol
exogen
cholesterol
use
filipin
iii
fluoresc
stain
cholesterol
cellular
cholesterol
level
specif
decreas
cell
treat
mm
mbcd
fig
b
slightli
decreas
cell
treat
mm
mbcd
data
shown
cellular
cholesterol
level
cell
treat
mm
mbcd
follow
addit
mgml
exogen
cholesterol
return
level
similar
cell
c
order
confirm
effect
cellular
deplet
cholesterol
fcov
infect
cell
pretreat
mbcd
rang
mm
mm
follow
viru
inocul
number
plaqu
caus
fcovi
reduc
mbcd
treatment
dosedepend
manner
fig
number
plaqu
caus
fcovii
reduc
cell
treat
mm
mbcd
show
signific
differ
treatment
control
mm
mbcd
contrast
number
plaqu
caus
vsv
affect
pretreat
mbcd
cholesteroldeplet
cell
replenish
addit
exogen
cholesterol
viru
inocul
order
determin
whether
cellular
cholesterol
import
fcovi
infect
number
plaqu
caus
fcovi
increas
treatment
exogen
cholesterol
dosedepend
manner
fig
contrast
number
plaqu
caus
fcovii
increas
slightli
vsv
affect
replenish
exogen
cholesterol
influenc
cellular
cholesterol
replic
type
fcov
investig
number
plaqu
caus
fcovi
fcovi
black
fcovi
reduc
treatment
mm
mbcd
fig
howev
exogen
cholesterol
restor
number
plaqu
caus
virus
dosedepend
manner
mg
exogen
cholesterol
per
ml
ad
number
plaqu
caus
fcovi
black
fcovi
significantli
higher
without
treatment
mbcd
exogen
cholesterol
contrast
cellular
cholesterol
cell
viabil
cell
viabil
mean
se
n
cell
viabil
cell
viabil
mean
se
n
fig
howev
addit
mg
exogen
cholesterol
per
ml
increas
number
plaqu
caus
typei
fcov
viru
titer
cultur
supernat
show
similar
chang
howev
signific
differ
note
fig
order
confirm
effect
cholesterol
deplet
envelop
fcov
viru
treat
mm
mbcd
prior
inocul
treatment
mbcd
reduc
number
plaqu
caus
fcovi
fig
exogen
cholesterol
restor
number
plaqu
caus
fcovi
dosedepend
manner
howev
signific
differ
note
fig
contrast
fcovi
viral
cholesterol
deplet
replenish
affect
number
plaqu
caus
fcovii
fcovinfect
cat
field
report
infect
type
fcov
find
demonstr
type
fcov
need
examin
detail
studi
prevent
treatment
felin
fcov
infect
howev
studi
use
type
fcov
conduct
date
propag
type
fcov
felin
cell
line
low
type
ii
fcov
use
felin
aminopeptidas
n
fapn
receptor
infect
cell
viru
studi
detail
contrast
viru
receptor
type
fcov
identifi
mechan
underli
cell
infect
yet
elucid
therefor
basic
analysi
type
fcov
need
develop
effect
antivir
drug
type
fcov
preval
field
present
studi
discov
depend
infect
cholesterol
differ
type
ii
fcov
recent
report
rate
inhibit
viral
replic
viroporin
inhibitor
differ
type
ii
fcov
base
find
desir
use
type
fcov
addit
type
ii
fcov
develop
effect
antivir
drug
deplet
cellular
cholesterol
cell
use
mbcd
cell
membran
cholesterol
extract
bind
hydrophob
core
mbcd
nystatin
frequent
use
well
mbcd
analyz
cholesteroldepend
viral
cell
infect
howev
sequest
rather
remov
cell
membran
cholesterol
moreov
strong
cytotox
note
cell
treat
nystatin
preliminari
experi
therefor
select
mbcd
involv
cholesterol
entri
envelop
viru
report
previous
base
type
cholesterol
depend
display
virus
divid
four
group
envelop
cholesterol
eg
influenza
viru
ii
cell
membran
cholesterol
eg
ebola
viru
iii
envelop
cell
membran
cholesterol
eg
human
immunodefici
viru
iv
cholesterol
involv
cell
infect
eg
vsv
coronavirus
mhv
sarscov
genu
betacoronaviru
belong
second
group
tgev
type
ii
canin
coronaviru
ccov
genu
alphacoronaviru
belong
third
group
base
result
type
fcov
belong
second
third
group
type
ii
fcov
belong
second
fourth
group
suggest
cholesterol
depend
infect
differ
fcov
type
ii
mbcd
slightli
inhibit
type
ii
fcov
replic
previou
report
show
cholesterol
slight
effect
infect
fcovii
suggest
type
ii
fcov
requir
much
cholesterol
infect
viru
receptor
type
ii
fcov
fapn
wherea
type
fcov
yet
identifi
teke
et
al
suggest
fapn
function
viru
receptor
type
fcov
although
ineffici
base
hypothesi
type
fcov
might
enter
cell
use
fapn
cofactor
coreceptor
mhv
fuse
cell
membran
util
cholesterol
bind
carcinoembryon
antigenrel
cell
adhes
molecul
ceacam
enter
cell
use
cholesterol
absenc
ceacam
cholesterol
may
also
function
essenti
cofactor
type
fcov
infect
furthermor
envelop
cholesterol
type
fcov
suggest
involv
infect
shown
figur
investig
need
order
determin
whether
envelop
cholesterol
type
fcov
play
import
role
cell
infect
although
current
remain
unclear
whether
result
present
studi
provid
direct
evid
regard
cell
entri
mechan
field
strain
type
fcov
may
use
determin
mechan
respons
previou
studi
fcov
replic
mechan
mainli
perform
use
type
ii
fcov
therefor
studi
may
use
previou
studi
use
type
ii
fcov
elucid
cell
entri
mechan
field
strain
type
fcov
studi
depend
infect
cholesterol
markedli
differ
type
ii
fcov
sinc
type
fcov
domin
field
studi
use
type
fcov
desir
result
may
use
obtain
deeper
understand
type
fcov
